1-10 of 10
OP Veiby
Close
Sort by
Journal Articles

Thrombopoietin, but not erythropoietin, directly stimulates multilineage growth of primitive murine bone marrow progenitor cells in synergy with early acting cytokines: distinct interactions with the ligands for c-kit and FLT3

V Ramsfjell, OJ Borge, OP Veiby, J Cardier, MJ Jr Murphy, SD Lyman, S Lok, SE Jacobsen
Journal: Blood
Blood (1996) 88 (12): 4481–4492.
https://doi.org/10.1182/blood.V88.12.4481.bloodjournal88124481
Published: 1996
Journal Articles

Human cytomegalovirus suppression of and latency in early hematopoietic progenitor cells

H Sindre, GE Tjoonnfjord, H Rollag, T Ranneberg-Nilsen, OP Veiby, S Beck, M Degre, K Hestdal
Journal: Blood
Blood (1996) 88 (12): 4526–4533.
https://doi.org/10.1182/blood.V88.12.4526.bloodjournal88124526
Published: 1996
Journal Articles

Thrombopoietin, but not erythropoietin promotes viability and inhibits apoptosis of multipotent murine hematopoietic progenitor cells in vitro

OJ Borge, V Ramsfjell, OP Veiby, MJ Jr Murphy, S Lok, SE Jacobsen
Journal: Blood
Blood (1996) 88 (8): 2859–2870.
https://doi.org/10.1182/blood.V88.8.2859.bloodjournal8882859
Published: 1996
Journal Articles

Combined signaling through interleukin-7 receptors and flt3 but not c- kit potently and selectively promotes B-cell commitment and differentiation from uncommitted murine bone marrow progenitor cells

OP Veiby, SD Lyman, SE Jacobsen
Journal: Blood
Blood (1996) 88 (4): 1256–1265.
https://doi.org/10.1182/blood.V88.4.1256.bloodjournal8841256
Published: 1996
Journal Articles

Ability of flt3 ligand to stimulate the in vitro growth of primitive murine hematopoietic progenitors is potently and directly inhibited by transforming growth factor-beta and tumor necrosis factor-alpha

SE Jacobsen, OP Veiby, J Myklebust, C Okkenhaug, SD Lyman
Journal: Blood
Blood (1996) 87 (12): 5016–5026.
https://doi.org/10.1182/blood.V87.12.5016.bloodjournal87125016
Published: 1996
Journal Articles

The FLT3 ligand is a direct and potent stimulator of the growth of primitive and committed human CD34+ bone marrow progenitor cells in vitro

LS Rusten, SD Lyman, OP Veiby, SE Jacobsen
Journal: Blood
Blood (1996) 87 (4): 1317–1325.
https://doi.org/10.1182/blood.V87.4.1317.bloodjournal8741317
Published: 1996
Journal Articles

Evidence for engraftment of donor-type multipotent CD34+ cells in a patient with selective T-lymphocyte reconstitution after bone marrow transplantation for B-SCID

GE Tjonnfjord, R Steen, OP Veiby, W Friedrich, T Egeland
Journal: Blood
Blood (1994) 84 (10): 3584–3589.
https://doi.org/10.1182/blood.V84.10.3584.3584
Published: 1994
Journal Articles

Tumor necrosis factor-alpha (TNF-alpha) potently enhances in vitro macrophage production from primitive murine hematopoietic progenitor cells in combination with stem cell factor and interleukin-7: novel stimulatory role of p55 TNF receptors

C Fahlman, FW Jacobsen, OP Veiby, IK McNiece, HK Blomhoff, SE Jacobsen
Journal: Blood
Blood (1994) 84 (5): 1528–1533.
https://doi.org/10.1182/blood.V84.5.1528.1528
Published: 1994
Journal Articles

Stem cell factor and interleukin-7 synergize to enhance early myelopoiesis in vitro

C Fahlman, HK Blomhoff, OP Veiby, IK McNiece, SE Jacobsen
Journal: Blood
Blood (1994) 84 (5): 1450–1456.
https://doi.org/10.1182/blood.V84.5.1450.1450
Published: 1994
Journal Articles

Functional differences between CD38- and DR- subfractions of CD34+ bone marrow cells

LS Rusten, SE Jacobsen, O Kaalhus, OP Veiby, S Funderud, EB Smeland
Journal: Blood
Blood (1994) 84 (5): 1473–1481.
https://doi.org/10.1182/blood.V84.5.1473.1473
Published: 1994